Breast Lesion Localization Methods Market: By Technology (Radio Isotope Localization (Radio Isotope Seed Localization (RSL), Radio Occult Lesion Localization (ROLL), Others), Wire Guided localization, Magnetic Tracker, Others), By End-User (Hospitals, Ambulatory Surgical Centers (ASC’s), and Others), By Geography  

Breast Lesion Localization Methods Market size was valued at USD 467.91 million in 2022 and is poised to grow at a CAGR of 6.6% from 2023-2029. Breast cancer is characterized by the abnormal multiplication of the breast cells that will form lumps that may be nonmalignant or malignant in nature. Such abnormal breast cells usually form tumors that may often observe on X-ray. Breast cancer occurs commonly in women above 40 years of age and often it can be seen in men also. For the early detection of lumps or lesions, various methods are used. Breast lesion localization methods are used to detect the nonpalatable suspicious breast lesions during the biopsy. The advent of novel technologies in breast localization methods such as electromagnetic reflectors and magnetic trackers and prevalence of the breast cancer worldwide are driving the breast lesion localization methods market. In addition, an increase in awareness about the early detection of breast cancer due to the different awareness campaigns and initiatives taken by the respective government and nonprofit organizations such as the Canadian Breast Cancer Foundation, American Cancer Society, and World Health Organization (WHO) expected to boost the market growth further. Moreover, favorable reimbursement policies in developed countries coupled with the rising demand for better healthcare infrastructure globally are projected to bolster market growth over the forecast period.